BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...

BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — Approved by the FDA in late January, the first balloon-expandable stent graft with an ...

Becton Dickinson (BDX) announced full enrollment of the iliac artery patient cohort in its AGILITY investigational device ...

Several balloon-expandable stents have been used in the iliac artery, however, they have not had a primary indication for iliac stenting. The Express® LD iliac premounted stent system (Boston ...

The FDA signed off on its Omnilink Elite vascular balloon-expandable stent system to treat iliac artery disease. The indication addresses a form of peripheral artery disease that can specifically hit ...

Background A 66-year-old man presented to hospital with gross hematuria and clots. He had previously undergone surgical repair of a right iliac artery aneurysm with placement of a vascular prosthesis ...

Stenting of iliac artery disease in patients with severely calcified lesions or extensive peripheral artery disease (PAD)—who historically have been excluded from clinical trials—is safe and effective ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced FDA approval of a self-expanding nitinol stent system for the treatment of iliac artery disease ...

Self-expanding polyethylene terephthalate and polytetrafluoroethylene (PTFE)-covered stents have been shown to decrease the need for repeat procedures in the iliac artery. [33] Similar to surgical ...